Sonoma Pharmaceuticals Inc (SNOA) stock news · rev $19.5M
Sonoma Pharmaceuticals Inc (SNOA) is a drug manufacturers - specialty & generic company listed on US.
This SNOA news page leads with what Sonoma Pharmaceuticals Inc filed — not a scraped headline mill.
No cached 8-K sentence for SNOA yet. We will not pad this page with generic market recap.
Latest reported SNOA revenue for 2026-03-31 was $19.5M. Net income was -$3.2M. Revenue was up 36.7% from 2025-03-31 to 2026-03-31. SNOA currently screens at market cap $4.9M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the SNOA stock page; for the tape open the quote page.
SNOA stock news FAQ
What are SNOA's latest revenue and net income?
Latest cached Sonoma Pharmaceuticals Inc (SNOA) revenue for Mar 31, 2026 was $19.5M. Net income was -$3.2M. Statements: https://lician.com/financials/snoa
How did SNOA revenue change from the prior cached period?
Cached Sonoma Pharmaceuticals Inc (SNOA) revenue was up 36.7% from $14.3M (Mar 31, 2025) to $19.5M (Mar 31, 2026). Statements: https://lician.com/financials/snoa
What is SNOA's market cap?
Sonoma Pharmaceuticals Inc (SNOA) market cap is $4.9M on the latest cached fundamentals snapshot.
What kind of company is SNOA?
Sonoma Pharmaceuticals Inc (SNOA) is a drug manufacturers - specialty & generic company listed on US.
Where is SNOA stock news listed?
Cached stock news for Sonoma Pharmaceuticals Inc (SNOA) is listed at https://lician.com/news/snoa. Filings: https://lician.com/sec/snoa
Not investment advice.